Diamond Hill Capital Management LLC Investment Advisor Invests $42.87 Million in Revvity Inc. $RVTY

Diamond Hill Capital Management LLC Investment Advisor purchased a new position in Revvity Inc. (NYSE:RVTY) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 385,296 shares of the company’s stock, valued at approximately $42,868,000. Diamond Hill Capital Management LLC Investment Advisor owned approximately 0.35% of Revvity at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. New Mexico Educational Retirement Board grew its holdings in Revvity by 1.9% in the fourth quarter. New Mexico Educational Retirement Board now owns 5,416 shares of the company’s stock worth $524,000 after purchasing an additional 100 shares during the period. Allworth Financial LP increased its stake in shares of Revvity by 8.9% during the fourth quarter. Allworth Financial LP now owns 1,275 shares of the company’s stock valued at $123,000 after purchasing an additional 104 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in shares of Revvity by 17.0% during the first quarter. EverSource Wealth Advisors LLC now owns 749 shares of the company’s stock valued at $66,000 after purchasing an additional 109 shares during the last quarter. HighTower Advisors LLC lifted its holdings in shares of Revvity by 2.6% during the fourth quarter. HighTower Advisors LLC now owns 5,141 shares of the company’s stock valued at $497,000 after purchasing an additional 129 shares during the last quarter. Finally, Cary Street Partners Financial LLC boosted its position in shares of Revvity by 1.6% in the 4th quarter. Cary Street Partners Financial LLC now owns 8,941 shares of the company’s stock worth $865,000 after purchasing an additional 141 shares in the last quarter. Institutional investors own 86.65% of the company’s stock.

Revvity Stock Performance

RVTY stock opened at $116.71 on Monday. The stock has a market capitalization of $13.02 billion, a PE ratio of 55.58, a price-to-earnings-growth ratio of 2.13 and a beta of 1.07. Revvity Inc. has a 12-month low of $81.22 and a 12-month high of $118.34. The company has a current ratio of 1.80, a quick ratio of 1.50 and a debt-to-equity ratio of 0.36. The stock’s 50 day simple moving average is $109.62 and its 200 day simple moving average is $99.98.

Revvity (NYSE:RVTY) last posted its earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.20. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The business had revenue of $729.69 million during the quarter, compared to analyst estimates of $702.96 million. During the same quarter last year, the company earned $1.18 EPS. The company’s quarterly revenue was down 1.3% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, research analysts forecast that Revvity Inc. will post 5.36 earnings per share for the current fiscal year.

Revvity Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 23rd. Revvity’s dividend payout ratio (DPR) is presently 13.33%.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on RVTY shares. Robert W. Baird set a $117.00 price target on Revvity in a research note on Wednesday, May 6th. Weiss Ratings raised Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 30th. TD Cowen restated a “buy” rating on shares of Revvity in a report on Wednesday, July 15th. Evercore reaffirmed an “outperform” rating on shares of Revvity in a research report on Wednesday, August 5th. Finally, Stifel Nicolaus dropped their price target on shares of Revvity from $110.00 to $100.00 and set a “hold” rating on the stock in a research note on Wednesday, May 6th. Three analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company’s stock. According to data from MarketBeat, Revvity has a consensus rating of “Hold” and a consensus price target of $108.36.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.